The results demonstrated that calretinin may be a useful adjunct to conventional diagnostic tools for accurately differentiating MM and MC, but should be interpreted in parallel with the gold standard of histological assessment and clinical findings when confirming diagnosis. The gene discussed is CALB2; the disease is Miyoshi myopathy.